Molecular basis of Fanconi anemia

Maria D'Apolito, Leopoldo Zelante, Anna Savoia

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background and Objective. Fanconi anemia (FA) is an autosomal recessive disease characterized by pancytopenia, congenital malformation and high predisposition to developing malignancies. The phenotypical heterogeneity is associated with genetic heterogeneity: at least 8 complementation groups (FA- A to FA-H) have been identified, each group presumably corresponding to a separate disease gene (FAA to FAH). The FAA and FAC genes, which account for 75-80% of the patients, have been cloned. Their protein products have no significant homology to any known protein, or to each other, and may therefore represent elements of a new pathway. This review describes some of the recent contributions to the understanding of the molecular basis of FA. Evidence and Information sources. The authors of the present review have been working in the field of FA for several years. In the present review they have critically examined articles published in Journals covered by the Science Citation Index and Medline. State of Art and Perspective(s). A variety of biochemical and cellular approaches have been used to determine the molecular defect of FA. Evidence for a possible role of the defective proteins in cell cycle regulation, apoptosis, or DNA stability have been reported. Recently, it has been demonstrated that FAA and FAC proteins bind each other and form a complex found in similar abundance in both cytoplasm and nucleus, suggesting a possible function in nucleus activities. Knowledge of the mutation spectrum occurring in the FA genes may contribute significantly to pathogenesis studies in FA and help to design mutation screening strategies. Further functional studies and the cloning of other FA genes will provide insights into the biological basis of FA and information for developing specific therapies for the disease.

Original languageEnglish
Pages (from-to)533-542
Number of pages10
JournalHaematologica
Volume83
Issue number6
Publication statusPublished - Jun 1998

Fingerprint

Fanconi Anemia
Genes
Cell Cycle Proteins
Pancytopenia
Mutation
Proteins
Genetic Heterogeneity
Organism Cloning
Cytoplasm
Apoptosis

Keywords

  • Complementation groups
  • FAA gene
  • FAC gene
  • Fanconi anemia
  • Mosaicism

ASJC Scopus subject areas

  • Hematology

Cite this

D'Apolito, M., Zelante, L., & Savoia, A. (1998). Molecular basis of Fanconi anemia. Haematologica, 83(6), 533-542.

Molecular basis of Fanconi anemia. / D'Apolito, Maria; Zelante, Leopoldo; Savoia, Anna.

In: Haematologica, Vol. 83, No. 6, 06.1998, p. 533-542.

Research output: Contribution to journalArticle

D'Apolito, M, Zelante, L & Savoia, A 1998, 'Molecular basis of Fanconi anemia', Haematologica, vol. 83, no. 6, pp. 533-542.
D'Apolito M, Zelante L, Savoia A. Molecular basis of Fanconi anemia. Haematologica. 1998 Jun;83(6):533-542.
D'Apolito, Maria ; Zelante, Leopoldo ; Savoia, Anna. / Molecular basis of Fanconi anemia. In: Haematologica. 1998 ; Vol. 83, No. 6. pp. 533-542.
@article{d362392f836347c894adbaa247ca1577,
title = "Molecular basis of Fanconi anemia",
abstract = "Background and Objective. Fanconi anemia (FA) is an autosomal recessive disease characterized by pancytopenia, congenital malformation and high predisposition to developing malignancies. The phenotypical heterogeneity is associated with genetic heterogeneity: at least 8 complementation groups (FA- A to FA-H) have been identified, each group presumably corresponding to a separate disease gene (FAA to FAH). The FAA and FAC genes, which account for 75-80{\%} of the patients, have been cloned. Their protein products have no significant homology to any known protein, or to each other, and may therefore represent elements of a new pathway. This review describes some of the recent contributions to the understanding of the molecular basis of FA. Evidence and Information sources. The authors of the present review have been working in the field of FA for several years. In the present review they have critically examined articles published in Journals covered by the Science Citation Index and Medline. State of Art and Perspective(s). A variety of biochemical and cellular approaches have been used to determine the molecular defect of FA. Evidence for a possible role of the defective proteins in cell cycle regulation, apoptosis, or DNA stability have been reported. Recently, it has been demonstrated that FAA and FAC proteins bind each other and form a complex found in similar abundance in both cytoplasm and nucleus, suggesting a possible function in nucleus activities. Knowledge of the mutation spectrum occurring in the FA genes may contribute significantly to pathogenesis studies in FA and help to design mutation screening strategies. Further functional studies and the cloning of other FA genes will provide insights into the biological basis of FA and information for developing specific therapies for the disease.",
keywords = "Complementation groups, FAA gene, FAC gene, Fanconi anemia, Mosaicism",
author = "Maria D'Apolito and Leopoldo Zelante and Anna Savoia",
year = "1998",
month = "6",
language = "English",
volume = "83",
pages = "533--542",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "6",

}

TY - JOUR

T1 - Molecular basis of Fanconi anemia

AU - D'Apolito, Maria

AU - Zelante, Leopoldo

AU - Savoia, Anna

PY - 1998/6

Y1 - 1998/6

N2 - Background and Objective. Fanconi anemia (FA) is an autosomal recessive disease characterized by pancytopenia, congenital malformation and high predisposition to developing malignancies. The phenotypical heterogeneity is associated with genetic heterogeneity: at least 8 complementation groups (FA- A to FA-H) have been identified, each group presumably corresponding to a separate disease gene (FAA to FAH). The FAA and FAC genes, which account for 75-80% of the patients, have been cloned. Their protein products have no significant homology to any known protein, or to each other, and may therefore represent elements of a new pathway. This review describes some of the recent contributions to the understanding of the molecular basis of FA. Evidence and Information sources. The authors of the present review have been working in the field of FA for several years. In the present review they have critically examined articles published in Journals covered by the Science Citation Index and Medline. State of Art and Perspective(s). A variety of biochemical and cellular approaches have been used to determine the molecular defect of FA. Evidence for a possible role of the defective proteins in cell cycle regulation, apoptosis, or DNA stability have been reported. Recently, it has been demonstrated that FAA and FAC proteins bind each other and form a complex found in similar abundance in both cytoplasm and nucleus, suggesting a possible function in nucleus activities. Knowledge of the mutation spectrum occurring in the FA genes may contribute significantly to pathogenesis studies in FA and help to design mutation screening strategies. Further functional studies and the cloning of other FA genes will provide insights into the biological basis of FA and information for developing specific therapies for the disease.

AB - Background and Objective. Fanconi anemia (FA) is an autosomal recessive disease characterized by pancytopenia, congenital malformation and high predisposition to developing malignancies. The phenotypical heterogeneity is associated with genetic heterogeneity: at least 8 complementation groups (FA- A to FA-H) have been identified, each group presumably corresponding to a separate disease gene (FAA to FAH). The FAA and FAC genes, which account for 75-80% of the patients, have been cloned. Their protein products have no significant homology to any known protein, or to each other, and may therefore represent elements of a new pathway. This review describes some of the recent contributions to the understanding of the molecular basis of FA. Evidence and Information sources. The authors of the present review have been working in the field of FA for several years. In the present review they have critically examined articles published in Journals covered by the Science Citation Index and Medline. State of Art and Perspective(s). A variety of biochemical and cellular approaches have been used to determine the molecular defect of FA. Evidence for a possible role of the defective proteins in cell cycle regulation, apoptosis, or DNA stability have been reported. Recently, it has been demonstrated that FAA and FAC proteins bind each other and form a complex found in similar abundance in both cytoplasm and nucleus, suggesting a possible function in nucleus activities. Knowledge of the mutation spectrum occurring in the FA genes may contribute significantly to pathogenesis studies in FA and help to design mutation screening strategies. Further functional studies and the cloning of other FA genes will provide insights into the biological basis of FA and information for developing specific therapies for the disease.

KW - Complementation groups

KW - FAA gene

KW - FAC gene

KW - Fanconi anemia

KW - Mosaicism

UR - http://www.scopus.com/inward/record.url?scp=0031871477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031871477&partnerID=8YFLogxK

M3 - Article

C2 - 9676027

AN - SCOPUS:0031871477

VL - 83

SP - 533

EP - 542

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 6

ER -